Axe Compute's EBIT is $-240M, below the Healthcare sector average of $22B.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026
The latest EBIT for AGPU is $-240M as of March 2026. That compares with $-9.9M in the prior-year period — down 2320.1% year over year. That is below the Healthcare sector average of $22B. Investors often review this figure alongside Axe Compute's historical trend and sector peers before judging valuation or financial health.
Over the past year, AGPU's EBIT moved from $-9.9M to $-240M — a 2320.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Axe Compute's operating scale or balance-sheet position.
Against Healthcare companies, AGPU currently prints $-240M for EBIT, while the sector average sits near $22B. That is roughly 101.1% below the sector mean. Large gaps often invite a closer look at Axe Compute's growth, margins, and balance sheet.
A EBIT figure of $-240M for AGPU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $22B. Explore the charts below for those layers of context.
After noting AGPU's EBIT ($-240M), review year-over-year change from $-9.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.